200 related articles for article (PubMed ID: 28068779)
1. Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults.
Marshe VS; Maciukiewicz M; Rej S; Tiwari AK; Sibille E; Blumberger DM; Karp JF; Lenze EJ; Reynolds CF; Kennedy JL; Mulsant BH; Müller DJ
Am J Psychiatry; 2017 May; 174(5):468-475. PubMed ID: 28068779
[TBL] [Abstract][Full Text] [Related]
2. SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese population.
Yeh YW; Chen CJ; Jang FL; Kuo SC; Chen CY; Liang CS; Ho PS; Yen CH; Shyu JF; Wan FJ; Lu RB; Huang SY
J Psychiatr Res; 2015 Feb; 61():33-9. PubMed ID: 25512257
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure.
Ahmed AT; Biernacka JM; Jenkins G; Rush AJ; Shinozaki G; Veldic M; Kung S; Bobo WV; Hall-Flavin DK; Weinshilboum RM; Wang L; Frye MA
J Affect Disord; 2019 Mar; 246():62-68. PubMed ID: 30578947
[TBL] [Abstract][Full Text] [Related]
4. Bone Turnover with Venlafaxine Treatment in Older Adults with Depression.
Rawson KS; Dixon D; Civitelli R; Peterson TR; Mulsant BH; Reynolds CF; Lenze EJ
J Am Geriatr Soc; 2017 Sep; 65(9):2057-2063. PubMed ID: 28555718
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older Adults.
Smagula SF; Butters MA; Anderson SJ; Lenze EJ; Dew MA; Mulsant BH; Lotrich FE; Aizenstein H; Reynolds CF
JAMA Psychiatry; 2015 Oct; 72(10):1021-8. PubMed ID: 26288246
[TBL] [Abstract][Full Text] [Related]
6. Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.
Lee SH; Choi TK; Lee E; Seok JH; Lee SH; Lee HS; Kim SJ
Neuropsychobiology; 2010 Aug; 62(3):198-206. PubMed ID: 20664233
[TBL] [Abstract][Full Text] [Related]
7. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF
JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
[TBL] [Abstract][Full Text] [Related]
8. The Catechol-O-methyltransferase Val(108/158)Met Genetic Polymorphism cannot be Recommended as a Biomarker for the Prediction of Venlafaxine Efficacy in Patients Treated in Psychiatric Settings.
Taranu A; Asmar KE; Colle R; Ferreri F; Polosan M; David D; Becquemont L; Corruble E; Verstuyft C
Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):435-441. PubMed ID: 28627776
[TBL] [Abstract][Full Text] [Related]
9. Predicting Remission in Late-Life Major Depression: A Clinical Algorithm Based Upon Past Treatment History.
Buchalter ELF; Oughli HA; Lenze EJ; Dixon D; Miller JP; Blumberger DM; Karp JF; Reynolds CF; Mulsant BH
J Clin Psychiatry; 2019 Dec; 80(6):. PubMed ID: 31846575
[TBL] [Abstract][Full Text] [Related]
10. Effect of Metabolic Syndrome on Late-Life Depression: Associations with Disease Severity and Treatment Resistance.
Mulvahill JS; Nicol GE; Dixon D; Lenze EJ; Karp JF; Reynolds CF; Blumberger DM; Mulsant BH
J Am Geriatr Soc; 2017 Dec; 65(12):2651-2658. PubMed ID: 29235659
[TBL] [Abstract][Full Text] [Related]
11. Self-reported obstructive sleep apnea is associated with nonresponse to antidepressant pharmacotherapy in late-life depression.
Waterman L; Stahl ST; Buysse DJ; Lenze EJ; Blumberger D; Mulsant B; Butters M; Gebara MA; Reynolds CF; Karp JF
Depress Anxiety; 2016 Dec; 33(12):1107-1113. PubMed ID: 27636232
[TBL] [Abstract][Full Text] [Related]
12. SERT and NET polymorphisms, temperament and antidepressant response.
Andre K; Kampman O; Illi A; Viikki M; Setälä-Soikkeli E; Mononen N; Lehtimäki T; Haraldsson S; Koivisto PA; Leinonen E
Nord J Psychiatry; 2015; 69(7):531-8. PubMed ID: 25739526
[TBL] [Abstract][Full Text] [Related]
13. Association between major depressive disorder and the norepinephrine transporter polymorphisms T-182C and G1287A: a meta-analysis.
Zhao X; Huang Y; Ma H; Jin Q; Wang Y; Zhu G
J Affect Disord; 2013 Aug; 150(1):23-8. PubMed ID: 23648227
[TBL] [Abstract][Full Text] [Related]
14. No association between CYP2C19 genetic polymorphism with treatment remission to antidepressant venlafaxine in Han Chinese population.
Zhang N; Ji L; Chen Z; An L; Ren D; Bi Y; Guo Z; Yuan R; Yuan F; Dong Z; Yin L; Sun X; Yang F; Li X; Yu T; He L; Shi L; He G
Psychiatr Genet; 2020 Feb; 30(1):30-33. PubMed ID: 31842058
[TBL] [Abstract][Full Text] [Related]
15. Association of common variations in the norepinephrine transporter gene with response to olanzapine-fluoxetine combination versus continued-fluoxetine treatment in patients with treatment-resistant depression: a candidate gene analysis.
Houston JP; Lau K; Aris V; Liu W; Fijal BA; Heinloth AN; Perlis RH
J Clin Psychiatry; 2012 Jun; 73(6):878-85. PubMed ID: 22480387
[TBL] [Abstract][Full Text] [Related]
16. Should a routine genotyping of CYP2D6 and CYP2C19 genetic polymorphisms be recommended to predict venlafaxine efficacy in depressed patients treated in psychiatric settings?
Taranu A; Colle R; Gressier F; El Asmar K; Becquemont L; Corruble E; Verstuyft C
Pharmacogenomics; 2017 May; 18(7):639-650. PubMed ID: 28480819
[TBL] [Abstract][Full Text] [Related]
17. Acute trajectories of neural activation predict remission to pharmacotherapy in late-life depression.
Karim HT; Wang M; Andreescu C; Tudorascu D; Butters MA; Karp JF; Reynolds CF; Aizenstein HJ
Neuroimage Clin; 2018; 19():831-839. PubMed ID: 30013927
[TBL] [Abstract][Full Text] [Related]
18. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
19. Impact of monoamine-related gene polymorphisms on hippocampal volume in treatment-resistant depression.
Phillips JL; Batten LA; Tremblay P; Aldosary F; Du L; Blier P
Acta Neuropsychiatr; 2015 Dec; 27(6):353-61. PubMed ID: 25990886
[TBL] [Abstract][Full Text] [Related]
20. TPH2 -703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression.
Yoon HK; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):403-9. PubMed ID: 19162119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
